Palliativ behandling af recurrensparalyse hos patienter med kræft og mediastinal involvering

Uffe Mark Lauridsen; Joyce Dominique Jacqueline Schultz; Christa Haugaard Nyhus; Jesper Roed Sørensen

Palliativ behandling af recurrensparalyse hos patienter med kræft og mediastinal involvering

Uffe Mark Lauridsen^*, Joyce Dominique Jacqueline Schultz, Christa Haugaard Nyhus, Jesper Roed Sørensen

^*Kontaktforfatter

Sygehus Lillebælt

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

15 Downloads (Pure)

Abstract

Injection augmentation of the vocal cords is a recognized treatment modality in patients with glottal closure deficiency caused by paresis or paralysis of the vocal cord. The treatment can improve voice quality and also quality of life. It is preferable to minimize waiting time for the procedure for patients with lung cancer and mediastinal involvement, because the one-year mortality is above 40%, as argued in this review.

Bidragets oversatte titel	Vocal cord augmentation in a palliative settingfor patients with lung cancer and mediastinal involvement
Originalsprog	Dansk
Artikelnummer	V05220332
Tidsskrift	Ugeskrift for Læger
Vol/bind	185
Udgave nummer	9
Sider (fra-til)	873-875
ISSN	0041-5782
Status	Udgivet - 1. maj 2023

Dokumenter og links

Open Access VersionForlagets udgivne version, 357 KBLicens: CC BY-NC-ND

https://ugeskriftet.dk/videnskab/palliativ-behandling-af-recurrensparalyse-hos-patienter-med-kraeft-og-mediastinalLicens: CC BY-NC-ND

Citationsformater

@article{0cebe969e6824846b723fd79cdfa2bea,

title = "Palliativ behandling af recurrensparalyse hos patienter med kr{\ae}ft og mediastinal involvering",

abstract = "Injection augmentation of the vocal cords is a recognized treatment modality in patients with glottal closure deficiency caused by paresis or paralysis of the vocal cord. The treatment can improve voice quality and also quality of life. It is preferable to minimize waiting time for the procedure for patients with lung cancer and mediastinal involvement, because the one-year mortality is above 40%, as argued in this review.",

author = "Lauridsen, {Uffe Mark} and {Dominique Jacqueline Schultz}, Joyce and {Haugaard Nyhus}, Christa and S{\o}rensen, {Jesper Roed}",

year = "2023",

month = may,

day = "1",

language = "Dansk",

volume = "185",

pages = "873--875",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "9",

}

TY - JOUR

T1 - Palliativ behandling af recurrensparalyse hos patienter med kræft og mediastinal involvering

AU - Lauridsen, Uffe Mark

AU - Dominique Jacqueline Schultz, Joyce

AU - Haugaard Nyhus, Christa

AU - Sørensen, Jesper Roed

PY - 2023/5/1

Y1 - 2023/5/1

N2 - Injection augmentation of the vocal cords is a recognized treatment modality in patients with glottal closure deficiency caused by paresis or paralysis of the vocal cord. The treatment can improve voice quality and also quality of life. It is preferable to minimize waiting time for the procedure for patients with lung cancer and mediastinal involvement, because the one-year mortality is above 40%, as argued in this review.

AB - Injection augmentation of the vocal cords is a recognized treatment modality in patients with glottal closure deficiency caused by paresis or paralysis of the vocal cord. The treatment can improve voice quality and also quality of life. It is preferable to minimize waiting time for the procedure for patients with lung cancer and mediastinal involvement, because the one-year mortality is above 40%, as argued in this review.

M3 - Tidsskriftartikel

AN - SCOPUS:85163752178

SN - 0041-5782

VL - 185

SP - 873

EP - 875

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

IS - 9

M1 - V05220332

ER -

Palliativ behandling af recurrensparalyse hos patienter med kræft og mediastinal involvering

Abstract

Dokumenter og links

Fingeraftryk

Citationsformater